HISTOGENICS CORP Business Finance Contracts & Agreements
54 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Equity Distribution Agreements (1)
- Exchange Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (1)
- Note Agreements (5)
- Purchase Agreements (10)
- Registration Rights Agreements (2)
- Stock Agreements (13)
- Underwriting Agreements (5)
- Warrant Agreements (13)
- Underwriting Agreement, dated July 31, 2024, by and between Ocugen, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC (Filed With SEC on August 1, 2024)
- Underwriting Agreement, dated May 24, 2023, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on May 25, 2023)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Inducement Restricted Stock Unit Awards (Filed With SEC on February 28, 2023)
- Form of Non-Qualified Stock Option Agreement for Inducement Non-Qualified Stock Option Awards (Filed With SEC on February 28, 2023)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on February 28, 2023)
- Form of Common Stock Purchase Warrant with Liminal (Filed With SEC on February 28, 2022)
- Underwriting Agreement, dated February 22, 2022, by and between Ocugen, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 25, 2022)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Inducement Restricted Stock Unit Awards (Filed With SEC on August 6, 2021)
- Form of Stock Option Agreement for Inducement Option Awards (Filed With SEC on August 6, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on April 27, 2021)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on March 19, 2021)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 19, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)
- Note dated April 30, 2020, between Ocugen, Inc. and Silicon Valley Bank (Filed With SEC on May 1, 2020)
- Form of Promissory Note dated April 22, 2020, issued by Ocugen Inc (Filed With SEC on April 22, 2020)
- Form of Amendment and Exchange Agreement dated as of April 22, 2020, by and between Ocugen, Inc., Ocugen Opco, Inc. and the Investor named therein (Filed With SEC on April 22, 2020)
- Form of Amendment to Warrants to Purchase Common Stock (Filed With SEC on November 6, 2019)
- Amendment No. 2 to Asset Purchase Agreement, dated October 4, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 7, 2019)
- Form of Series C Investor Warrant (Filed With SEC on October 7, 2019)
- Form of Series B Investor Warrant (Filed With SEC on October 7, 2019)
- Form of Series A Investor Warrant (Filed With SEC on October 7, 2019)
- Amendment No. 1 to Asset Purchase Agreement, dated September 26, 2019, by and between the Company and Medavate Corp (Filed With SEC on October 1, 2019)
- Form of Amendment to Securities Purchase Agreement, dated as of June 28, 2019, by and among Histogenics Corporation, Ocugen, Inc. and the investor named therein (Filed With SEC on July 3, 2019)
- Security Agreement, dated as of May 21, 2019, by Ocugen, Inc. in favor of HB Fund LLC, in its capacity as collateral agent for the investors party to the Securities Purchase... (Filed With SEC on June 14, 2019)
- Form of Senior Secured Convertible Note, dated as of May 21, 2019, by Ocugen, Inc. to each of the investors party to the Securities Purchase Agreement, dated as of May 21, 2019 (Filed With SEC on June 14, 2019)
- Securities Purchase Agreement, dated as of May 21, 2019, by and among Ocugen, Inc. and the investors party thereto (Filed With SEC on June 14, 2019)
- Form of Nonstatutory Stock Option Agreement under Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)
- Ocugen, Inc. 2014 Stock Option Plan (Filed With SEC on June 14, 2019)
- Securities Purchase Agreement, dated as of June 13, 2019, by and among Histogenics Corporation, Ocugen, Inc. and certain investors named therein (Filed With SEC on June 14, 2019)
- Registration Rights Agreement, dated as of June 13, 2019, by and among Histogenics Corporation and certain investors named therein (Filed With SEC on June 14, 2019)
- Form of Series C Warrant (Filed With SEC on June 14, 2019)
- Asset Purchase Agreement dated May 8, 2019 by and between Histogenics Corporation and Medavate Corp (Filed With SEC on May 13, 2019)
- Form of 2018 Warrant Exercise Agreement (Filed With SEC on February 8, 2019)
- Form of 2016 Warrant Amendment and Exercise Agreement (Filed With SEC on February 8, 2019)
- Form of Warrant (Filed With SEC on October 5, 2018)
- Underwriting Agreement, dated October 5, 2018, by and between the Company and Canaccord Genuity LLC (Filed With SEC on October 5, 2018)
- Equity Distribution Agreement, dated as of March 15, 2018, by and between Histogenics Corporation and Canaccord Genuity, Inc (Filed With SEC on March 15, 2018)
- Underwriting Agreement between Histogenics Corporation and Canaccord Genuity Inc., dated January 22, 2018 (Filed With SEC on January 23, 2018)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 29, 2016)
- COMMON STOCK PURCHASE WARRANT HISTOGENICS CORPORATION (Filed With SEC on September 29, 2016)
